Breast Lift in Indianapolis Indiana
Breast Lift in Indianapolis section, includes general infrmation about Breast Lift Procedure, Breast Lift Indianapolis Local News, Breast Lift Indianapolis Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift indianapolis (current)
indianapolis Breast Reduction
indianapolis Breast Implants
indianapolis Implant Removal
indianapolis Armpit Incision
More Indianapolis info...
Plastic Surgery News...
- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending the granting of a marketing authorisation for interferon beta-1b (Extavia, 250 microgram/ml, powder and solvent for solution for injection) for the treatment of:
• Patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis.
• Patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years.
• Patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.
- Data from a Phase I/II study of the novel antiCD20 monoclonal antibody, ofatumumab (formerly HuMax-CD20) in patients with relapsed or refractory B-cell chronic lymphocytic leukaemia (CLL) demonstrate anti-tumour responses in half of the patients treated in one of the three cohorts.[1] The study is published in the February issue of the journal Blood.